These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9721941)

  • 21. Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety.
    Gatch MB
    Life Sci; 2003 Aug; 73(11):1347-67. PubMed ID: 12850497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormonal and subjective responses to intravenous meta-chlorophenylpiperazine in bulimia nervosa.
    Levitan RD; Kaplan AS; Joffe RT; Levitt AJ; Brown GM
    Arch Gen Psychiatry; 1997 Jun; 54(6):521-7. PubMed ID: 9193192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects.
    Broocks A; Meyer T; Gleiter CH; Hillmer-Vogel U; George A; Bartmann U; Bandelow B
    Psychopharmacology (Berl); 2001 May; 155(3):234-41. PubMed ID: 11432685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-chlorophenylpiperazine induced changes in locomotor activity are mediated by 5-HT1 as well as 5-HT2C receptors in mice.
    Gleason SD; Shannon HE
    Eur J Pharmacol; 1998 Jan; 341(2-3):135-8. PubMed ID: 9543230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys.
    Aloi JA; Insel TR; Mueller EA; Murphy DL
    Life Sci; 1984 Apr; 34(14):1325-31. PubMed ID: 6708733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.
    Krystal JH; Webb E; Cooney NL; Kranzler HR; Southwick SW; Heninger GR; Charney DS
    Am J Psychiatry; 1996 Jan; 153(1):83-92. PubMed ID: 8540598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia.
    Brewerton TD; Mueller EA; Lesem MD; Brandt HA; Quearry B; George DT; Murphy DL; Jimerson DC
    Arch Gen Psychiatry; 1992 Nov; 49(11):852-61. PubMed ID: 1444722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval.
    Nappi RE; Sances G; Brundu B; De Taddei S; Sommacal A; Ghiotto N; Polatti F; Nappi G
    Hum Reprod; 2005 Dec; 20(12):3423-8. PubMed ID: 16123089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects.
    Seibyl JP; Krystal JH; Price LH; Woods SW; D'Amico C; Heninger GR; Charney DS
    Psychiatry Res; 1991 Sep; 38(3):227-36. PubMed ID: 1754635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased tryptophan availability but normal post-synaptic 5-HT2c receptor sensitivity in chronic fatigue syndrome.
    Vassallo CM; Feldman E; Peto T; Castell L; Sharpley AL; Cowen PJ
    Psychol Med; 2001 May; 31(4):585-91. PubMed ID: 11352361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonin in migraine: theories, animal models and emerging therapies.
    Johnson KW; Phebus LA; Cohen ML
    Prog Drug Res; 1998; 51():219-44. PubMed ID: 9949863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia.
    Krystal JH; Seibyl JP; Price LH; Woods SW; Heninger GR; Aghajanian GK; Charney DS
    Arch Gen Psychiatry; 1993 Aug; 50(8):624-35. PubMed ID: 8102048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms.
    Krystal JH; Webb E; Cooney N; Kranzler HR; Charney DS
    Arch Gen Psychiatry; 1994 Nov; 51(11):898-911. PubMed ID: 7944878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central serotonergic effects of m-chlorophenylpiperazine (mCPP) among normal control adolescents.
    Ghaziuddin N; Welch K; Greden J
    Neuropsychopharmacology; 2003 Jan; 28(1):133-9. PubMed ID: 12496949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile.
    Feuchtl A; Bagli M; Stephan R; Frahnert C; Kölsch H; Kühn KU; Rao ML
    Pharmacopsychiatry; 2004 Jul; 37(4):180-8. PubMed ID: 15467976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. m-Chlorophenylpiperazine as a probe of serotonin function.
    Kahn RS; Wetzler S
    Biol Psychiatry; 1991 Dec; 30(11):1139-66. PubMed ID: 1663792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of meta-chlorophenylpiperazine on neuroendocrine and behavioral responses in male schizophrenic patients and normal volunteers.
    Maes M; Meltzer HY
    Psychiatry Res; 1996 Oct; 64(3):147-59. PubMed ID: 8944393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lower baseline plasma cortisol and prolactin together with increased body temperature and higher mCPP-induced cortisol responses in men with pedophilia.
    Maes M; van West D; De Vos N; Westenberg H; Van Hunsel F; Hendriks D; Cosyns P; Scharpé S
    Neuropsychopharmacology; 2001 Jan; 24(1):37-46. PubMed ID: 11106874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroendocrine and behavioral responses to mCPP in Obsessive-Compulsive Disorder.
    Khanna S; John JP; Reddy LP
    Psychoneuroendocrinology; 2001 Feb; 26(2):209-23. PubMed ID: 11087965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hostility is associated with a heightened prolactin response to meta-chlorophenylpiperazine in abstinent cocaine addicts.
    Handelsman L; Kahn RS; Sturiano C; Rinaldi PJ; Gabriel S; Schmeidler JP; Bernstein DP; Siever L; Cooper TB
    Psychiatry Res; 1998 Jul; 80(1):1-12. PubMed ID: 9727959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.